Invention Grant
- Patent Title: Dosage regimen of paliperidone palmitate extended-release injectable suspension
-
Application No.: US16759287Application Date: 2018-10-26
-
Publication No.: US11666573B2Publication Date: 2023-06-06
- Inventor: Youxin Li , Chunjie Sha , Fengjuan Zhao , Changbing Tu , Kaoxiang Sun , Wanhui Liu , Lifang Sun , Ying Meng
- Applicant: Geneora Pharma (Shijiazhuang) Co., Ltd.
- Applicant Address: CN Shijiazhuang
- Assignee: Geneora Pharma (Shijiazhuang) Co., Ltd.
- Current Assignee: Geneora Pharma (Shijiazhuang) Co., Ltd.
- Current Assignee Address: CN Shijiazhuang
- Agency: Seed IP Law Group LLP
- International Application: PCT/US2018/057858 2018.10.26
- International Announcement: WO2019/084501A 2019.05.02
- Date entered country: 2020-04-24
- Main IPC: A61K31/519
- IPC: A61K31/519 ; A61K9/00
Abstract:
Provided herein are simplified dosing regimens for administering paliperidone palmitate to a patient in need of treatment of schizophrenia or schizoaffective disorders.
Public/Granted literature
- US20200297729A1 DOSAGE REGIMEN OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION Public/Granted day:2020-09-24
Information query
IPC分类:
